US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Crown Bioscience
Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development
July 16, 2026
From
Crown Bioscience
Via
Business Wire
AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals
April 16, 2026
From
Crown Bioscience
Via
Business Wire
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
January 20, 2026
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory
October 30, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina
September 17, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
July 22, 2025
From
Crown Bioscience
Via
JCN Newswire
Tickers
MKGAF
MKKGY
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
July 22, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Named Fierce CRO Award Winner for Excellence in Global Operations
June 24, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Achieves Green Lab Sustainability Certification
May 07, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience and NEXT Oncology Cement Partnership Extension
May 01, 2025
From
Crown Bioscience
Via
Business Wire
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies
April 28, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Appoints John Gu as Chief Executive Officer
March 13, 2025
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
October 01, 2024
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
August 21, 2024
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
April 11, 2024
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
March 28, 2024
From
Crown Bioscience
Via
Business Wire
Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
January 23, 2024
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
November 07, 2023
From
Crown Bioscience
Via
Business Wire
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
September 11, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
August 22, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank
April 04, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Opens Singapore Laboratory and Establishes Local Commercial Partner
March 09, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
January 25, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery
January 05, 2023
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership
July 28, 2022
From
Crown Bioscience
Via
Business Wire
Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels
June 03, 2021
From
Crown Bioscience
Via
Business Wire
CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings
May 05, 2021
From
Crown Bioscience
Via
Business Wire
